Eton Pharmaceuticals, Inc. Inventory, Work in Process, Gross
Eton Pharmaceuticals, Inc. (ETON) had Inventory, Work in Process, Gross of $5.50 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-13
- 2026-06-30: Inventory, Work in Process, Gross $5.50M.
- 2026-03-31: Inventory, Work in Process, Gross $7.44M.
- 2025-12-31: Inventory, Work in Process, Gross $9.43M.
- 2024-12-31: Inventory, Work in Process, Gross $3.29M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $5.50M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $7.44M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $9.43M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $3.29M 10-K · filed 2026-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |